Evidence map›Paper›PMID 24587016›Full record

ArticlePloS one2014

A heritable antiviral RNAi response limits Orsay virus infection in Caenorhabditis elegans N2.

Mark G Sterken, L Basten Snoek, Kobus J Bosman, Jikke Daamen, Joost A G Riksen, Jaap Bakker, Gorben P Pijlman, Jan E Kammenga

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Small RNAs and chromatin in the multigenerational epigenetic landscape ofPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Balancing Selection of the Intracellular Pathogen Response in NaturalFrontiers in cellular and infection microbiology · 2021
    Article
  18. Article
  19. Genetic Variation inMicroorganisms · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mark G SterkenLaboratory of Nematology, Wageningen University, Wageningen, The Netherlands ; Laboratory of Virology, Wageningen University, Wageningen, The Netherlands.
L Basten SnoekLaboratory of Nematology, Wageningen University, Wageningen, The Netherlands.
Kobus J BosmanLaboratory of Nematology, Wageningen University, Wageningen, The Netherlands.
Jikke DaamenLaboratory of Nematology, Wageningen University, Wageningen, The Netherlands.
Joost A G RiksenLaboratory of Nematology, Wageningen University, Wageningen, The Netherlands.
Jaap BakkerLaboratory of Nematology, Wageningen University, Wageningen, The Netherlands.
Gorben P PijlmanLaboratory of Virology, Wageningen University, Wageningen, The Netherlands.
Jan E KammengaLaboratory of Nematology, Wageningen University, Wageningen, The Netherlands.

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440
6 · The paper itself

Abstract

Orsay virus (OrV) is the first virus known to be able to complete a full infection cycle in the model nematode species Caenorhabditis elegans. OrV is transmitted horizontally and its infection is limited by antiviral RNA interference (RNAi). However, we have no insight into the kinetics of OrV replication in C. elegans. We developed an assay that infects worms in liquid, allowing precise monitoring of the infection. The assay revealed a dual role for the RNAi response in limiting Orsay virus infection in C. elegans. Firstly, it limits the progression of the initial infection at the step of recognition of dsRNA. Secondly, it provides an inherited protection against infection in the offspring. This establishes the heritable RNAi response as anti-viral mechanism during OrV infections in C. elegans. Our results further illustrate that the inheritance of the anti-viral response is important in controlling the infection in the canonical wild type Bristol N2. The OrV replication kinetics were established throughout the worm life-cycle, setting a standard for further quantitative assays with the OrV-C. elegans infection model.

Indexed as

Disease Models, AnimalAnalysis of VarianceAnimalsCaenorhabditis elegansDNA PrimersInheritance PatternsNodaviridaeReverse Transcriptase Polymerase Chain ReactionRNA InterferenceRNA, ViralRNA Virus InfectionsVirus ReplicationDNA PrimersRNA, Viral

Identifiers

PMID24587016
PMCPMC3933659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.